middle.news
How Did Invion Handle FDA Orphan Drug News for Anal Cancer So Quickly?
2:18am on Saturday 30th of August, 2025 AEST
•
Healthcare
Read Story
How Did Invion Handle FDA Orphan Drug News for Anal Cancer So Quickly?
2:18am on Saturday 30th of August, 2025 AEST
Key Points
FDA granted Orphan Drug Designation for INV043 in anal cancer
Invion became aware of FDA decision on 19 August 2025
Announcement made promptly on 20 August 2025 after verification
No prior direct communication from FDA; information sourced from FDA website
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Invion (ASX:IVX)
OPEN ARTICLE